According to Vision Research Reports, the Non-invasive Aesthetic Treatment market size is expected to be worth around US$ 150 billion by 2030 from valued at US$ 49 billion in 2020 and growing at a CAGR of 15.7% from 2021 to 2030.
According to Vision Research Reports, the Non-invasive Aesthetic Treatment market size is expected to be worth around US$ 150 billion by 2030 from valued at US$ 49 billion in 2020 and growing at a CAGR of 15.7% from 2021 to 2030.
Growth Factors
Growing focus on physical appearance among adults has led to an increased demand for non-invasive aesthetic treatment in recent years. Another key revenue-generating population to watch out for are the ones aged 50+ years and above. Women in this age group are opting for fillers and injectable including the popular, Botox. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2019, around 3.8 million minimally invasive cosmetic surgeries were carried out in the US within the age group of 55 and above. The COVID-19 pandemic has significantly affected the non-invasive aesthetic treatment market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in inpatient interest owing to a sharp cut in income level. The market for non-invasive aesthetic treatment is expected to witness a phase of short-term negative growth.
Full Report is Ready | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39012
By Procedure Analysis
The injectables segment dominated the market for non-invasive aesthetic treatment and accounted for the largest revenue share of 64.0% in 2021. Injectables can be easily used by surgeons and provide faster treatment with quick results and less downtime as compared to others.
Laser hair removal is fast gaining popularity as it is cost-effective and saves time compared to waxing, shaving, or using hair removal cream. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was among the top 5 nonsurgical procedures carried out at a global level in 2020.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 150.0 billion by 2030 |
| Growth Rate | CAGR of 15.7% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Procedure, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Allergan; Hologic (cynosure); Johnson & Johnson; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser |
By End-use Analysis
The medspa segment dominated the market for non-invasive aesthetic treatment accounted for the largest revenue share of 33.9% in 2021. The end-user segment is divided into Hospital/Surgery Center, Medspa, Traditional Spa, HCP owned clinics.
Medspa is a facility where cosmetic services are provided under the supervision of a licensed physician. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals.
Medspas are increasingly adopting novel treatment systems to cater to a wider esthetic need of patients, therefore the segment is witnessing growth. The employees in Medspas need to have a license in esthetics as well as a medical education.
By Regional Analysis
North America dominated the market for non-invasive aesthetic treatment and held the largest revenue share of 38.4% in 2021 owing to increasing demand for cosmetic procedures by both adults and the geriatric population.
In the Asia Pacific, the market for non-invasive aesthetic treatment is expected to witness the highest CAGR of 16.6% during the forecast period. The region is backed by countries such as China, India, and Thailand.
Key Players
- Hologic, Inc.
- Allergan, Inc.
- Galderma S.A
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis
- Solta
- Cutera Inc.
Market Segmentation
- Procedure Type
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
- Injectables
- End-use
- Hospital/Surgery Center
- Medspa
- Traditional Spa
- HCP owned clinic
- Regional
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39012
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333